Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity - Another target for chondroprotective intervention

Journal of Rheumatology

Volumn 27, Issue 2, 2000, Pages 332-338

  Bell, Michael C ^a   Carroll, Graeme J ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Arthritis; Cartilage; Cytokine; Leukemia Inhibitory Factor

Indexed keywords

GLYCOSAMINOGLYCAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEUKEMIA INHIBITORY FACTOR; RECOMBINANT INTERLEUKIN 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTICULAR CARTILAGE; BONE ATROPHY; CARTILAGE CELL; CATABOLISM; CELL PROTECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; HYPOTHESIS; JOINT FUNCTION; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; CARTILAGE; CELLS, CULTURED; CHONDROCYTES; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; OSTEOARTHRITIS; PROTEOGLYCANS; SWINE; SYNOVIAL FLUID;

EID: 0033962721     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. McDonnell J, Hoemer LA, Lark MW, et al. Recombinant human interleukin-1 beta induced increase in levels of proteoglycans, stromelysin and leukocytes in rabbit synovial fluid. JOURNAL 1992;35:799-805.
2. Morales TI, Hascall VC. Factors involved in the regulation of proteoglycan metabolism in articular cartilage. Arthritis Rheum 1989;32:1197-201.
3. Nietfeld JJ, Wilbrink B, van der Otter W, Huber J, Huber-Bruning O. Factors involved in the regulation of proteoglycan metabolism in articular cartilage. J Rheumatol 1990;17:818-26.
4. Pettipher ER, Higgs GA, Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 1986;83:8749-53.
5. Van Beuningen HM, Arntz OJ, van den Berg WB. In vivo effects of interleukin-1 on articular cartilage. Arthritis Rheumatism 1991;34:606-15.
6. Tyler JA. The influence of IL-1 and IGF-1 on the integrity of cartilage matrix. In: Glauert AM, editor. The control of tissue damage. Amsterdam: Elsevier; 1988:197-214.
7. Saklatvala J. Tumour necrosis factor stimulates resorption and inhbiits synthesis of proteoglycan in cartilage. Nature 1986;322:547-9.
8. Morales TI. Transforming growth factor beta stimulates synthesis of proteoglycan aggregates in calf articular cartilage organ cultures. Arch Biochem Biophys 1991;286:99-106.
9. Tyler JA. Insulin like growth factor I can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem J 1989;260:543-8.
10. Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR. Transforming growth factor beta is a potent inhibitor of interleukin-1 receptor expression: proposed mechanism for the inhibition of IL-1 action. J Exp Med 1990;172:737-44.
11. Hollander AP, Dieppe PA, Atkins RM, Elson CJ. Hypothesis: cartilage catabolic cofactors in human arthritis. J Rheumatol 1993;20:223-4.
12. Hilton DJ, Nicola NA, Gough N, Metcalf D. Resolution and purification of three distinct factors produced by Krebs ascites cells which have differentiation and inducing activity on murine myeloid leukaemic cell lines. J Biol Chem 1988;263:9238-43.
13. Anegar I, Moreau JF, Godard A, et al. Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes. Cell Immunol 1990;130:50-6.
14. Gearing DP, Gough NM, King JA, et al. Molecular cloning and expression of cDNA encoding a murine leukaemic inhibitor) Factor. EMBO J 1987;13:3995-4002.
15. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M. Purification of a factor inducing differentiation of mouse myeloid M1 cells from conditioned medium of mouse fibroblasts L929 cells. J Biol Chem 1984;259:10978-82.
16. Koopman P, Cotton RGH. A factor produced by feeder cells which inhibits embryonal carcinoma cell differentiation: characterization and partial purification. Exp Cell Res 1984;154:233-42.
17. Smith AG, Hooper ML. Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol 1987;121:1-9.
18. Abe E, Tanaka H, Ishimi Y, et al. Differentiation inducing factor purified from conditioned media of niitogen stimulated spleen cell cultures stimulates bone resorption. Proc Natl Acad Sci USA 1986;83:5958-62.
19. Lotz M, Moats T, Villiger PM. Leukaemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest 1992;90:888-96.
20. Baumann H, Wong GG. Hepatocyte-stimulating factor-III shares structural and functional identity with leukaemia inhibitory factor. J Immunol 1989;143:1163-7.
21. Goddard A, Gasian H, Namlet J, et al. Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood 1988;71:1618-23.
22. Gough NM, Williams RL. The pleiotropic actions of leukaemia inhibitory factor. Cancer Cells 1989;1:77-80.
23. Metcalf D. The leukaemia inhibitory factor. Int J Cell Cloning 1991;9:95-108.
24. Metcalf D, Nicola NA, Gearing DP. Effects of injected leukaemia inhibitory factor on haematopoietic and other tissues in mice. Blood 1990;76:50-6.
25. Mori M, Yamaguchi K, Abe K. Identification of a lipoprotein lipase inhibitory protein produced by a melanoma cell line associated with cancer cachexia. Biochem Biophys Res Commun 1989; 160:1085-92.
26. Reid IR, Lowe C, Cornish J, et al. Leukaemia inhibitory factor: a novel bone-active cytokine. Endocrinology 1990;126:1416-20.
27. Cornish J, Callon K, King A, Edgar S, Reid IR. The effect of leukaemia inhibitory factor on bone in vivo. Endocrinology 1993;132:1359-66.
28. Carroll GJ, Bell MC. Leukaemia inhibitory factor stimulates proteoglycan resorption in porcine articular cartilage. Rheumatol Int 1993;13:5-8.
29. Bell MC, Carroll GJ. Leukaemia inhibitory factor suppresses proteoglycan synthesis in porcine and caprine cartilage explants. Cytokine 1995;7:137-41.
30. Carroll GJ, Bell MC, Chapman HM, Mills JN, Robinson WF. Leukemia inhibitory factor induces leukocyte infiltration and cartilage proteoglycan degradation in goat joints. J Interferon Cytokine Res 1995;15:567-73.
31. Waring PM, Carroll GJ, Kandiah DA, Buirski G, Metcalf D. Increased levels of leukaemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1993;36:911-5.
32. Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992;258:593-7.
33. Hirano T, Matsuda T, Nakajima K. Signal transduction through gpl30 that is shared among the receptors for the interleukin-6 related cytokine subfamily. Stem Cells 1994;12:262-77.
34. Layton MJ, Cross BA, Metcalf D, Ward LD, Simpson RJ, Nicola NA. A major binding protein for leukaemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor. Proc Natl Acad Sci USA 1992;89:8616-20.
35. Bell MC, Carroll GJ, Chapman H, Layton M, Mills J. Leukemia inhibitory factor binding protein attenuates the phlogistic and abolishes the chondral effects of LIF in goat joints. J Rheumatol 1997;24:2394-402.
36. Wang H, Bell MC, Carroll GJ, Layton J. Modulation of cartilage proteoglycan metabolism by LIF binding protein. Cytokine 1998;10:220-8.
37. Elliott MJ, Maerc RN, Feldmann M, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 1993;36:1681-90.
38. Campion GV, Lebsack ME, Lookabaugh J, Gordon G, Catalano M, and the IL-1 Ra Arthritis Study Group. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1092-101.
39. Silvermann ED, Smith RE, Scaurman DJ, Miller JJ. The effect of juvenile inflammatory synovial fluid on in vitro cartilage. J Rheumatol 1984;11:798-803.
40. Saxne T, Heinegard D, Wollheim FA. Human arthritic synovial fluid influences proteoglycan biosynthesis and degradation in organ culture of bovine nasal cartilage. Collagen Rel Res 1988;8:233-47.
41. Dingle JT, Horsfield P, Fell HB, Barrett MEJ. Breakdown of proteoglycan and collagen induced in pig articular cartilage in organ culture. Ann Rheum Dis 1975;34:303-11.
42. Farridale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. J Biochem Biophys Acta 1986;883:173-7.
43. Wang H, Bell MC, Carroll GJ. Oncostatin M stimulates resorption and inhibits synthesis of proteoglycan in pig cartilage explants. Cytokine 1996;8:495-500.
44. Wang H, Bell M, Carroll G. Detection of oncostatin M in the synovial fluid of patients with rheumatoid arthritis. Ann Rheum Dis 1997;56:1-4.
45. Rooney M, Symons JA, Duff GW. Interleukin-1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis. Rheumatol Int 1990;10:217-9.
46. Cawston TE, Ellis AJ, Humm G, Lean E, Ward D, Curry V. Interleukin-1 and oncostatin M in combination promote the release of collagen fragments in bovine nasal cartilage in culture. Biochem Biophys Res Commun 1995;215:377-85.